title: Minimal important difference and responsiveness to change of the SF-36 in patients with psoriatic arthritis receiving tumor necrosis factor-α blockers.
authors: Ying-Ying
authors: YY
authors: Leung
authors: Tracy Yaner
authors: TY
authors: Zhu
authors: Lai Shan
authors: LS
authors: Tam
authors: Emily Wai-Lin
authors: EW
authors: Kun
authors: Edmund Kwok-Ming
authors: EK
authors: Li
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy* / Q000503:physiopathology; D004056:Differential Threshold / Q000187:drug effects; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D006304:Health Status; D006801:Humans; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha